ZimVie Newsroom

ZimVie Inc (ZIMV) Gets a Sell From Barclays

TipRanksNov 13 05:21 ET

Needham Maintains ZimVie(ZIMV.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsOct 31 05:33 ET

ZimVie Analyst Ratings

BenzingaAug 2 06:05 ET

Needham Maintains ZimVie(ZIMV.US) With Buy Rating, Raises Target Price to $23

Moomoo NewsAug 2 05:34 ET

Buy Rating Affirmed for ZimVie Inc. Amid Market Challenges and Positive Growth Indicators

TipRanksAug 2 05:17 ET

ZimVie Analyst Ratings

BenzingaJun 25 13:16 ET

Needham Reiterates Buy on ZimVie, Maintains $20 Price Target

BenzingaJun 25 13:14 ET

ZimVie Analyst Ratings

BenzingaMay 16 07:27 ET

Barclays Sticks to Their Sell Rating for ZimVie Inc (ZIMV)

TipRanksMay 10 06:06 ET

ZimVie Analyst Ratings

BenzingaMay 9 06:08 ET

Needham Sticks to Their Hold Rating for ZimVie Inc (ZIMV)

TipRanksMay 9 05:25 ET

ZimVie Analyst Ratings

BenzingaApr 11 05:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)

TipRanksApr 11 05:45 ET

ZimVie Analyst Ratings

BenzingaMar 5 06:48 ET

Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)

TipRanksMar 5 03:15 ET

Needham Sticks to Its Hold Rating for ZimVie Inc (ZIMV)

TipRanksFeb 29 06:15 ET

ZimVie Inc (ZIMV) Gets a Hold From Needham

TipRanksFeb 8 05:26 ET

ZimVie Analyst Ratings

BenzingaJan 4 08:13 ET

ZimVie Analyst Ratings

BenzingaDec 20, 2023 15:26 ET

Needham Keeps Their Hold Rating on ZimVie Inc (ZIMV)

TipRanksDec 18, 2023 12:35 ET